Ovarian cancer screening study for gynecologists
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether using AI can help gynecologists screen average-risk women for ovarian cancer. It's for gynecologists who already offer this screening, even though it's not standard practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a gynecologist working in outpatient care
- You provide ovarian cancer screening to women at average risk who have no symptoms
- Your screening practice is not in line with current medical guidelines
- You do not work in a hospital or inpatient setting
- You have not stopped offering this screening to average-risk women
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a nudge or reminder can help doctors refer patients with suspicious ovarian masses to a gynecologic oncologist. If you have a finding on an imaging test that suggests possible ovarian cancer, this study may help connect you with the right specialist.
This trial uses artificial intelligence to guide personalized treatment for people with a specific type of ovarian cancer (high-grade serous carcinoma). It aims to improve outcomes by analyzing your tumor tissue and medical history.
This trial tests a computer program (artificial intelligence) that looks at CT scans of the pelvis to help find ovarian cancer. If it works, it could help doctors diagnose this cancer earlier and more accurately.
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
This trial is looking at how doctors can better use the CA125 blood test to find ovarian cancer earlier. If you are being tested for ovarian cancer in primary care, this study might help improve how future patients are diagnosed.
This study is testing an AI system that uses your ultrasound or MRI images and blood test results to help doctors better diagnose ovarian tumors before surgery. It may lead to more accurate treatment planning.
Hear when a new Ovarian Cancer Screening Recommendations by Gynecologists trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.